$35.03 0.00 (%) Teva Pharma Ind Shs Sponsored American Deposit Receipt Repr 1 Sh - New York Stock Exchange, Inc.

Dec. 6, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. TherapeuticsMD Soars On Positive Menopause Drug Trial Results

    Investors Business Daily | Dec. 5, 2016 | 17:28PM EST
  2. 50 Companies Going Ex-Dividend This Week Including KO, PEP, HD, K And MCD

    TalkMarkets | Nov. 29, 2016 | 12:01PM EST
  3. Better Than The Maestro

    TalkMarkets | Nov. 28, 2016 | 23:53PM EST
  4. Data Presented at ACR, Bristol-Myers Inks Immuno-Oncology Deal

    TalkMarkets | Nov. 18, 2016 | 08:30AM EST
  5. A Stock Bubble

    TalkMarkets | Nov. 17, 2016 | 10:32AM EST
  6. 6 Things You Need To Know About Teva's Q3 Earnings

    TalkMarkets | Nov. 16, 2016 | 13:15PM EST
  7. Teva (TEVA) Q3 Earnings Top but Revenues Lag Estimates

    TalkMarkets | Nov. 15, 2016 | 10:36AM EST
  8. 5 Stocks To Watch That Report Earnings Tomorrow - Tuesday, Nov. 15

    TalkMarkets | Nov. 14, 2016 | 17:01PM EST
  9. Pharmaceutical Stocks Surge After Republican Victory

    TalkMarkets | Nov. 9, 2016 | 12:48PM EST
  10. Buy Health Care Now? It All Depends On The Election

    TalkMarkets | Nov. 7, 2016 | 01:10AM EST
  11. Generic Drugs Probe Seen As Possible 'Severe' Sector Overhang

    TalkMarkets | Nov. 4, 2016 | 13:40PM EST
  12. S&P 500 Index Posted Its 8th Consecutive Loss

    TalkMarkets | Nov. 4, 2016 | 00:30AM EST
  13. Drugs, Finance, Cars, And Fuel

    TalkMarkets | Nov. 1, 2016 | 11:57AM EST
  14. Why After A Massive Run, CoLucid Shares Still Look Attractive

    TalkMarkets | Oct. 31, 2016 | 09:02AM EST
  15. Best Stock Charts - October 30, 2016

    TalkMarkets | Oct. 30, 2016 | 22:30PM EST
  16. Teva, IBM announce significant expansion of e-Health alliance

    TalkMarkets | Oct. 26, 2016 | 07:31AM EST
  17. Global Roundup: Roche, Vale, Novo Nordisk, Teva, Benitec Et Al

    TalkMarkets | Oct. 21, 2016 | 19:05PM EST
  18. 7 Drug Stocks To Consider As Biosimilars Pick Up Pace

    TalkMarkets | Oct. 20, 2016 | 13:53PM EST
  19. Clarifying Confusion Over Mylan's EpiPen Profits

    TalkMarkets | Oct. 9, 2016 | 01:27AM EST
  20. Week In Review: Teva Pays $160 Million For US/Canada Rights To Celltrion Biosimilars

    TalkMarkets | Oct. 8, 2016 | 13:30PM EST
  21. Has Gold Lost Its Glimmer?

    TalkMarkets | Oct. 6, 2016 | 06:36AM EST
  22. The Internet Of Medical Things: 6 Stocks In Focus

    TalkMarkets | Sep. 26, 2016 | 12:20PM EST
  23. How Will Healthcare Stocks Be Affected If Donald Trump Wins?

    Dividend.com | Sep. 12, 2016 | 11:00AM EST
  24. How Will Healthcare Stocks Be Affected If Hillary Clinton Wins?

    Dividend.com | Sep. 12, 2016 | 10:00AM EST
  25. Alder Biopharma Migraine Drug Holds Up After 6 Months

    Investors Business Daily | Jul. 25, 2016 | 10:05AM EST
  26. California Leads Nation In Tech, Lifesciences IPOs

    IBD | Feb. 12, 2016 | 14:46PM EST
  27. Gurus Are Buying High-Yield Stocks Like WestRock, Target

    GuruFocus | Feb. 9, 2016 | 16:34PM EST
  28. Top Stocks 2015: Biotechs, Wayfair, Netflix, Amazon

    IBD | Dec. 30, 2015 | 08:02AM EST
  29. Takeda Provides Update About New Business Venture in Japan with Teva

    Benzinga | Dec. 27, 2015 | 18:02PM EST
  30. 5 Guru Picks in Volatile Biotech Industry

    GuruFocus | Dec. 23, 2015 | 14:24PM EST
  31. NWQ Managers Reduces Stakes in Microsoft, MetLife and Teva Pharmaceutical

    GuruFocus | Dec. 23, 2015 | 12:13PM EST
  32. Benzinga's Top Initiations

    Benzinga | Dec. 7, 2015 | 09:43AM EST
  33. GoPro PT Cut; Chipotle, Bluebird Bio Downgraded

    IBD | Dec. 7, 2015 | 08:56AM EST
  34. Benzinga's Volume Movers

    Benzinga | Dec. 3, 2015 | 10:34AM EST
  35. Top Performing Industries For December 1, 2015

    Benzinga | Dec. 1, 2015 | 10:36AM EST
  36. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga | Nov. 30, 2015 | 07:18AM EST
  37. Teva Announces Proposed Public Offerings Of Amer Depositary Shrs And Mandatory Convertible Preferred Shares In Connection With Pending Acquisition Of Actavis Generics

    Benzinga | Nov. 30, 2015 | 06:54AM EST
  38. Teva, Takeda Establish Partnership in Japan; Teva to Own 51% Stake, Takeda to Own 49% Stake

    Benzinga | Nov. 30, 2015 | 04:22AM EST
  39. Teva, Heptares Announce Agreement to Discover and Develop Novel, Small-Molecule CGRP Antagonists for Treatment of Migraine

    Benzinga | Nov. 25, 2015 | 04:13AM EST
  40. Benzinga's Top Upgrades

    Benzinga | Nov. 23, 2015 | 08:56AM EST
  41. Pfizer, Allergan Set To Unveil $150 Billion Inversion

    IBD | Nov. 22, 2015 | 22:55PM EST
  42. John Paulson Increases Holding in Teva Pharmaceutical

    GuruFocus | Nov. 17, 2015 | 16:08PM EST
  43. John Paulson Keeps Gold, Buys Drug Manufacturers in Q3

    GuruFocus | Nov. 17, 2015 | 13:13PM EST
  44. Mylan, Perrigo Face Off As Takeover Vote Nears

    IBD | Nov. 12, 2015 | 12:18PM EST
  45. Ronald Muhlenkamp's Highest-Yielding Stocks

    GuruFocus | Nov. 10, 2015 | 17:47PM EST
  46. Teva Announces Breakthrough Therapy Designation for SD-809 Granted by FDA for the Treatment of Tardive Dyskinesia

    Benzinga | Nov. 10, 2015 | 08:06AM EST
  47. Allergan Beats Q3 Estimates Amid M&A, Pricing Talk

    IBD | Nov. 4, 2015 | 11:58AM EST
  48. Roche Touts New MS Drug As Legacy Players Hit Snags

    IBD | Nov. 3, 2015 | 08:02AM EST
  49. Allergan Confirms Pfizer Talks

    IBD | Oct. 29, 2015 | 17:53PM EST
  50. Teva Pharmaceutical's

    IBD | Oct. 29, 2015 | 17:51PM EST
Trading Center